Secreted and transmembrane polypeptides and nucleic acids encoding the same
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
1. An isolated nuleic acid comprising:
(a) the nuleic acid sequence of SEQ ID NO:95
(b) the full-length coding sequence of nucleic acid sequence of SEQ ID NO:95; or
(c) the full-length coding sequence of the cDNA deposited under ATCC accession number 209397.
2. The isolated nucleic acid of claim 1 comprising the nucleic acid sequence of SEQ ID NO:95.
3. The isolated nucleic acid of claim 1 comprising the full-length coding sequence of the nucleic acid sequence of SEQ ID NO:95.
4. The isolated nucleic acid of claim 1 comprising the full-length coding sequence of the cDNA deposited under ATCC accession number 209397.
5. A vector comprising the nucleic acid of claim 1 .
6. The vector of claim 5 , wherein said nucleic acid is operably linked to control sequences recognized by a host cell transformed with the vector.
7. A host cell comprising the vector of claim 5 .
8. The host cell of claim 7 , wherein said cell is a CHO cell, an E. coli or a yeast cell.
9. An isolated nucleic acid consisting of an at least 30 nucleotide fragment of the nucleic acid sequence of SEQ ID NO:95, or the complement thereof, that specifically hybridizes under stringent hybridization conditions to:
(a) the nucleic acid sequence of SEQ ID NO:95, or the complement thereof;
(b) the full-length coding sequence of the nucleic acid sequence of SEQ ID NO:95, or the complement thereof; or
(c) the full-length coding sequence of the cDNA deposited under ATCC accession number 209397, or the complement thereof;
wherein the stringent hybridization conditions are hybridization in 50% formamide, 5×SSC (0.75M NaCI, 0.075M sodium citrate), 50 mM sodium phosphate (pH 6.8), 0.1% sodium pyrophosphate 5× Denhardt's solution, sonicated salmon sperm DNA (50 μg/ml), 0.1% SDS and 10% dextran sulfate at42° C. with washes at 42° C. in 0.2×SSC (sodium chloride/sodium citrate) and 50% forrnamide, followed by a high stringency wash consisting of 0.1×SSC containing EDTA at 55° C.
10. The nucleic acid of claim 9 consisting of at feast 50 nucleotides of SEQ ID NO:95, or the complement thereof.
11. The nucleic acid of claim 9 consisting of at least 100 nucleotides of SEQ ID NO:95, or the complement thereof.